Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edelstein, S. L.
Right arrow Articles by Hamman, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edelstein, S. L.
Right arrow Articles by Hamman, R. F.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 46, Issue 4 701-710, Copyright © 1997 by American Diabetes Association

ARTICLES

Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies

SL Edelstein, WC Knowler, RP Bain, R Andres, EL Barrett-Connor, GK Dowse, SM Haffner, DJ Pettitt, JD Sorkin, DC Muller, VR Collins and RF Hamman
George Washington University Biostatistics Center, Rockville, Maryland 20852, USA. sharone@biostat.bsc.gwu.edu

Risk factors associated with the progression from impaired glucose tolerance (IGT) to NIDDM were examined in data from six prospective studies. IGT and NIDDM were defined in all studies by World Health Organization (WHO) criteria, and baseline risk factors were measured at the time of first recognition of IGT. The studies varied in size from 177 to 693 participants with IGT, and included men and women followed from 2 to 27 years after the recognition of IGT. Across the six studies, the incidence rate of NIDDM was 57.2/1,000 person-years and ranged from 35.8/1,000 to 87.3/1,000 person-years. Although baseline measures of fasting and 2-h postchallenge glucose levels were both positively associated with NIDDM incidence, incidence rates were sharply higher for those in the top quartile of fasting plasma glucose levels, but increased linearly with increasing 2-h postchallenge glucose quartiles. Incidence rates were higher among the Hispanic, Mexican-American, Pima, and Nauruan populations than among Caucasians. The effect of baseline age on NIDDM incidence rates differed among the studies; the rates did not increase or rose only slightly with increasing baseline age in three of the studies and formed an inverted U in three studies. In all studies, estimates of obesity (including BMI, waist-to-hip ratio, and waist circumference) were positively associated with NIDDM incidence. BMI was associated with NIDDM incidence independently of fasting and 2-h post challenge glucose levels in the combined analysis of all six studies and in three cohorts separately, but not in the three studies with the highest NIDDM incidence rates. Sex and family history of diabetes were generally not related to NIDDM progression. This analysis indicates that persons with IGT are at high risk and that further refinement of risk can be made by other simple measurements. The ability to identify persons at high risk of NIDDM should facilitate clinical trials in diabetes prevention.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
P. W. Franks, R. L. Hanson, W. C. Knowler, C. Moffett, G. Enos, A. M. Infante, J. Krakoff, and H. C. Looker
Childhood Predictors of Young-Onset Type 2 Diabetes
Diabetes, December 1, 2007; 56(12): 2964 - 2972.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
D.-T. Lin-Tan, J.-L. Lin, L.-H. Wang, L.-M. Wang, L.-M. Huang, L. Liu, J.-Y. Huang, and Y.-L. Huang
Fasting Glucose Levels in Predicting 1-Year All-Cause Mortality in Patients Who Do Not Have Diabetes and Are on Maintenance Hemodialysis
J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2385 - 2391.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
D. Yeste, J. Vendrell, R. Tomasini, M. Broch, M. Gussinye, A. Megia, and A. Carrascosa
Interleukin-6 in Obese Children and Adolescents With and Without Glucose Intolerance
Diabetes Care, July 1, 2007; 30(7): 1892 - 1894.
[Full Text] [PDF]

Home page
 DiabetesHome page
D. Fradin, S. Heath, M. Lathrop, and P. Bougneres
Quantitative Trait Loci for Fasting Glucose in Young Europeans Replicate Previous Findings for Type 2 Diabetes in 2q23-24 and Other Locations
Diabetes, June 1, 2007; 56(6): 1742 - 1745.
[Abstract] [Full Text] [PDF]

Home page
 Epidemiol RevHome page
G. Vazquez, S. Duval, D. R. Jacobs Jr., and K. Silventoinen
Comparison of Body Mass Index, Waist Circumference, and Waist/Hip Ratio in Predicting Incident Diabetes: A Meta-Analysis
Epidemiol. Rev., May 10, 2007; (2007) mxm008v1.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
C. L Gillies, K. R Abrams, P. C Lambert, N. J Cooper, A. J Sutton, R. T Hsu, and K. Khunti
Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis
BMJ, February 10, 2007; 334(7588): 299 - 299.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. E. van Genugten, K. M. Utzschneider, J. Tong, F. Gerchman, S. Zraika, J. Udayasankar, E. J. Boyko, W. Y. Fujimoto, S. E. Kahn, and and the American Diabetes Association GENNID Study
Effects of Sex and Hormone Replacement Therapy Use on the Prevalence of Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance in Subjects With a Family History of Type 2 Diabetes
Diabetes, December 1, 2006; 55(12): 3529 - 3535.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
D. Thornley-Brown, X. Wang, J. T. Wright Jr, O. S. Randall, E. R. Miller, J. P. Lash, J. Gassman, G. Contreras, L. J. Appel, L. Y. Agodoa, et al.
Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease.
Arch Intern Med, April 10, 2006; 166(7): 797 - 805.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. B. Racette, E. M. Evans, E. P. Weiss, J. M. Hagberg, and J. O. Holloszy
Abdominal adiposity is a stronger predictor of insulin resistance than fitness among 50-95 year olds.
Diabetes Care, March 1, 2006; 29(3): 673 - 678.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Tasali, E. Van Cauter, and D. A. Ehrmann
Relationships between Sleep Disordered Breathing and Glucose Metabolism in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 36 - 42.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
H. Zhou, D. J.M. Isaman, S. Messinger, M. B. Brown, R. Klein, M. Brandle, and W. H. Herman
A Computer Simulation Model of Diabetes Progression, Quality of Life, and Cost
Diabetes Care, December 1, 2005; 28(12): 2856 - 2863.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes Spectr.Home page
R. K. Danish and B. B. West
Rapid Progression From Pre-diabetes to Severely Ill Diabetes While Under "Expert Care": Suggestions for Improved Screening for Disease Progression
Diabetes Spectr, October 1, 2005; 18(4): 229 - 239.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Public HealthHome page
S. B. Austin, S. J. Melly, B. N. Sanchez, A. Patel, S. Buka, and S. L. Gortmaker
Clustering of Fast-Food Restaurants Around Schools: A Novel Application of Spatial Statistics to the Study of Food Environments
Am J Public Health, September 1, 2005; 95(9): 1575 - 1581.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
The Diabetes Prevention Program Research Group
Role of Insulin Secretion and Sensitivity in the Evolution of Type 2 Diabetes in the Diabetes Prevention Program: Effects of Lifestyle Intervention and Metformin
Diabetes, August 1, 2005; 54(8): 2404 - 2414.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
The Diabetes Prevention Program Research Group
Intensive Lifestyle Intervention or Metformin on Inflammation and Coagulation in Participants With Impaired Glucose Tolerance
Diabetes, May 1, 2005; 54(5): 1566 - 1572.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
The Diabetes Prevention Program Research Group
Impact of Intensive Lifestyle and Metformin Therapy on Cardiovascular Disease Risk Factors in the Diabetes Prevention Program
Diabetes Care, April 1, 2005; 28(4): 888 - 894.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Weiss, S. E. Taksali, W. V. Tamborlane, T. S. Burgert, M. Savoye, and S. Caprio
Predictors of Changes in Glucose Tolerance Status in Obese Youth
Diabetes Care, April 1, 2005; 28(4): 902 - 909.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. L. Johnson, B. P. Tabaei, and W. H. Herman
The Efficacy and Cost of Alternative Strategies for Systematic Screening for Type 2 Diabetes in the U.S. Population 45-74 Years of Age
Diabetes Care, February 1, 2005; 28(2): 307 - 311.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. M. Kanaya, C. L. W. Fyr, N. de Rekeneire, R. I. Shorr, A. V. Schwartz, B. H. Goodpaster, A. B. Newman, T. Harris, and E. Barrett-Connor
Predicting the Development of Diabetes in Older Adults: The derivation and validation of a prediction rule
Diabetes Care, February 1, 2005; 28(2): 404 - 408.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
The Diabetes Prevention Program Research Group
Strategies to Identify Adults at High Risk for Type 2 Diabetes: The Diabetes Prevention Program
Diabetes Care, January 1, 2005; 28(1): 138 - 144.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
V. Lyssenko, P. Almgren, D. Anevski, R. Perfekt, K. Lahti, M. Nissen, B. Isomaa, B. Forsen, N. Homstrom, C. Saloranta, et al.
Predictors of and Longitudinal Changes in Insulin Sensitivity and Secretion Preceding Onset of Type 2 Diabetes
Diabetes, January 1, 2005; 54(1): 166 - 174.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
D. C Anderson Jr
Pharmacologic Prevention or Delay of Type 2 Diabetes Mellitus
Ann. Pharmacother., January 1, 2005; 39(1): 102 - 109.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. P. Stern, K. Williams, C. Gonzalez-Villalpando, K. J. Hunt, and S. M. Haffner
Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease?
Diabetes Care, November 1, 2004; 27(11): 2676 - 2681.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. J. Manning, W. H.F. Sutherland, R. J. Walker, S. M. Williams, S. A. de Jong, A. R. Ryalls, and E. A. Berry
Effect of High-Dose Vitamin E on Insulin Resistance and Associated Parameters in Overweight Subjects
Diabetes Care, September 1, 2004; 27(9): 2166 - 2171.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. B. D'Agostino Jr, R. F. Hamman, A. J. Karter, L. Mykkanen, L. E. Wagenknecht, and S. M. Haffner
Cardiovascular Disease Risk Factors Predict the Development of Type 2 Diabetes: The Insulin Resistance Atherosclerosis Study
Diabetes Care, September 1, 2004; 27(9): 2234 - 2240.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
N. Younis, H. Soran, and S. Farook
The prevention of type 2 diabetes mellitus: recent advances
QJM, July 1, 2004; 97(7): 451 - 455.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. J.G. Hanley, A. Festa, R. B. D'Agostino, L. E. Wagenknecht, P. J. Savage, R. P. Tracy, M. F. Saad, and S. M. Haffner
Metabolic and Inflammation Variable Clusters and Prediction of Type 2 Diabetes: Factor Analysis Using Directly Measured Insulin Sensitivity
Diabetes, July 1, 2004; 53(7): 1773 - 1781.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
Centers for Disease Control and Prevention Primary
Primary Prevention of Type 2 Diabetes Mellitus by Lifestyle Intervention: Implications for Health Policy
Ann Intern Med, June 1, 2004; 140(11): 951 - 957.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Prevention or Delay of Type 2 Diabetes
Diabetes Care, January 1, 2004; 27(90001): s47 - 47.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
D. M. Eddy and L. Schlessinger
Archimedes: A trial-validated model of diabetes
Diabetes Care, November 1, 2003; 26(11): 3093 - 3101.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
J. W. Anderson, C. W.C. Kendall, and D. J.A. Jenkins
Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies
J. Am. Coll. Nutr., October 1, 2003; 22(5): 331 - 339.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
E. Ros
Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes
Am. J. Clinical Nutrition, September 1, 2003; 78(3): 617S - 625.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
K. C.B. Tan, N. M.S. Wat, S. C.F. Tam, E. D. Janus, T.H. Lam, and K. S.L. Lam
C-Reactive Protein Predicts the Deterioration of Glycemia in Chinese Subjects With Impaired Glucose Tolerance
Diabetes Care, August 1, 2003; 26(8): 2323 - 2328.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. E. Molitch, W. Fujimoto, R. F. Hamman, and W. C. Knowler
The Diabetes Prevention Program and Its Global Implications
J. Am. Soc. Nephrol., July 1, 2003; 14(90002): S103 - 107.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. B. Meigs, D. C. Muller, D. M. Nathan, D. R. Blake, and R. Andres
The Natural History of Progression From Normal Glucose Tolerance to Type 2 Diabetes in the Baltimore Longitudinal Study of Aging
Diabetes, June 1, 2003; 52(6): 1475 - 1484.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C.J. Sumner, S. Sheth, J.W. Griffin, D.R. Cornblath, and M. Polydefkis
The spectrum of neuropathy in diabetes and impaired glucose tolerance
Neurology, January 14, 2003; 60(1): 108 - 111.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
The Prevention or Delay of Type 2 Diabetes
Diabetes Care, January 1, 2003; 26(90001): s62 - 69.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
D. Liao, P. J. Asberry, J. B. Shofer, H. Callahan, C. Matthys, E. J. Boyko, D. Leonetti, S. E. Kahn, M. Austin, L. Newell, et al.
Improvement of BMI, Body Composition, and Body Fat Distribution With Lifestyle Modification in Japanese Americans With Impaired Glucose Tolerance
Diabetes Care, September 1, 2002; 25(9): 1504 - 1510.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
R G. Barr, D. M. Nathan, J. B. Meigs, and D. E. Singer
Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus
Ann Intern Med, August 20, 2002; 137(4): 263 - 272.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
E. Barrett-Connor
The oral glucose tolerance test, revisited
Eur. Heart J., August 2, 2002; 23(16): 1229 - 1231.
[PDF]

Home page
 Clin. DiabetesHome page
The Prevention or Delay of Type 2 Diabetes
Clin. Diabetes, July 1, 2002; 20(3): 109 - 116.
[Full Text] [PDF]

Home page
 Diabetes Spectr.Home page
The Prevention or Delay of Type 2 Diabetes
Diabetes Spectr, July 1, 2002; 15(3): 147 - 157.
[Full Text] [PDF]

Home page
 DiabetesHome page
C. C. Jensen, M. Cnop, R. L. Hull, W. Y. Fujimoto, S. E. Kahn, and the American Diabetes Association GENNID Study Gro
{beta}-Cell Function Is a Major Contributor to Oral Glucose Tolerance in High-Risk Relatives of Four Ethnic Groups in the U.S.
Diabetes, July 1, 2002; 51(7): 2170 - 2178.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. M. Lindgren, E. Widen, T. Tuomi, H. Li, P. Almgren, T. Kanninen, O. Melander, J. Weng, M. Lehto, and L. C. Groop
Contribution of Known and Unknown Susceptibility Genes to Early-Onset Diabetes in Scandinavia: Evidence for Heterogeneity
Diabetes, May 1, 2002; 51(5): 1609 - 1617.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
American Diabetes Association
The Prevention or Delay of Type 2 Diabetes
Diabetes Care, April 1, 2002; 25(4): 742 - 749.
[Full Text] [PDF]

Home page
 NEJMHome page
R. Sinha, G. Fisch, B. Teague, W. V. Tamborlane, B. Banyas, K. Allen, M. Savoye, V. Rieger, S. Taksali, G. Barbetta, et al.
Prevalence of Impaired Glucose Tolerance among Children and Adolescents with Marked Obesity
N. Engl. J. Med., March 14, 2002; 346(11): 802 - 810.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. B. Meigs, C. I. M. Panhuysen, R. H. Myers, P. W.F. Wilson, and L. A. Cupples
A Genome-Wide Scan for Loci Linked to Plasma Levels of Glucose and HbA1c in a Community-Based Sample of Caucasian Pedigrees: The Framingham Offspring Study
Diabetes, March 1, 2002; 51(3): 833 - 840.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
Diabetes Prevention Program Research Group
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
N. Engl. J. Med., February 7, 2002; 346(6): 393 - 403.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. J. Franz, J. P. Bantle, C. A. Beebe, J. D. Brunzell, J.-L. Chiasson, A. Garg, L. A. Holzmeister, B. Hoogwerf, E. Mayer-Davis, A. D. Mooradian, et al.
Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications
Diabetes Care, January 1, 2002; 25(1): 148 - 198.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
H. C. Gerstein
Fasting Versus Postload Glucose Levels: Why the controversy?
Diabetes Care, November 1, 2001; 24(11): 1855 - 1857.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
H. C. Looker, W. C. Knowler, and R. L. Hanson
Changes in BMI and Weight Before and After the Development of Type 2 Diabetes
Diabetes Care, November 1, 2001; 24(11): 1917 - 1922.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
K. A. Myers
Lifestyle changes can prevent the development of diabetes mellitus
Can. Med. Assoc. J., June 1, 2001; 164(13): 1885 - 1885.
[Full Text] [PDF]

Home page
 NEJMHome page
P. A. Tataranni and C. Bogardus
Changing Habits to Delay Diabetes
N. Engl. J. Med., May 3, 2001; 344(18): 1390 - 1392.
[Full Text] [PDF]

Home page
 JAMAHome page
F. de Vegt, J. M. Dekker, A. Jager, E. Hienkens, P. J. Kostense, C. D. A. Stehouwer, G. Nijpels, L. M. Bouter, and R. J. Heine
Relation of Impaired Fasting and Postload Glucose With Incident Type 2 Diabetes in a Dutch Population: The Hoorn Study
JAMA, April 25, 2001; 285(16): 2109 - 2113.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. J. Mayer-Davis
Low-Fat Diets for Diabetes Prevention
Diabetes Care, April 1, 2001; 24(4): 613 - 614.
[Full Text]

Home page
 Diabetes CareHome page
B. A. Swinburn, P. A. Metcalf, and S. J. Ley
Long-Term (5-Year) Effects of a Reduced-Fat Diet Intervention in Individuals With Glucose Intolerance
Diabetes Care, April 1, 2001; 24(4): 619 - 624.
[Abstract] [Full Text]

Home page
 J. Nutr.Home page
S. E. Kahn, R. L. Prigeon, R. S. Schwartz, W. Y. Fujimoto, R. H. Knopp, J. D. Brunzell, and D. Porte Jr.
Obesity, Body Fat Distribution, Insulin Sensitivity and Islet {{beta}}-Cell Function as Explanations for Metabolic Diversity
J. Nutr., February 1, 2001; 131(2): 354S - 360.
[Abstract] [Full Text]

Home page
 JRSM